# Brillant Blue Versus Indocyanine Green for Macular Hole Surgery

> **NCT00757471** · NA · COMPLETED · sponsor: **The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery** · enrollment: 60 (actual)

## Conditions studied

- Idiopathic Macular Holes

## Interventions

- **PROCEDURE:** Brillant Blue
- **PROCEDURE:** Indocyanine Green

## Key facts

- **NCT ID:** NCT00757471
- **Lead sponsor:** The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-08
- **Primary completion:** 2015-08
- **Final completion:** 2015-08
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2016-01-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00757471

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00757471, "Brillant Blue Versus Indocyanine Green for Macular Hole Surgery". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00757471. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*